These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 36241061)
61. Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease. Hutchison CA; Harding S; Hewins P; Mead GP; Townsend J; Bradwell AR; Cockwell P Clin J Am Soc Nephrol; 2008 Nov; 3(6):1684-90. PubMed ID: 18945993 [TBL] [Abstract][Full Text] [Related]
62. Quantification of Free Immunoglobulin Light Chains in Urine. Singh G; Cotter T; Ye Mon M; Xu H; Bollag RJ J Appl Lab Med; 2023 Nov; 8(6):1101-1114. PubMed ID: 37725944 [TBL] [Abstract][Full Text] [Related]
63. A novel approach for the purification and proteomic analysis of pathogenic immunoglobulin free light chains from serum. Lavatelli F; Brambilla F; Valentini V; Rognoni P; Casarini S; Di Silvestre D; Perfetti V; Palladini G; Sarais G; Mauri P; Merlini G Biochim Biophys Acta; 2011 Mar; 1814(3):409-19. PubMed ID: 21215335 [TBL] [Abstract][Full Text] [Related]
64. Inter-assay diagnostic accuracy of cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis. Dekeyser C; De Kesel P; Cambron M; Vanopdenbosch L; Van Hijfte L; Vercammen M; Laureys G Front Immunol; 2024; 15():1385231. PubMed ID: 38745673 [TBL] [Abstract][Full Text] [Related]
65. Establishment and validation of serum free light chain reference intervals in an ethnic Chinese population. Liang YF; Chen WM; Wang QT; Zhai YH; Yang YJ; Liu JY; Levoguer A; Sun WH Clin Lab; 2014; 60(2):193-8. PubMed ID: 24660530 [TBL] [Abstract][Full Text] [Related]
66. Evaluation of the N Latex free light chain assay in the diagnosis and monitoring of AL amyloidosis. Mollee P; Tate J; Pretorius CJ Clin Chem Lab Med; 2013 Dec; 51(12):2303-10. PubMed ID: 23934643 [TBL] [Abstract][Full Text] [Related]
67. Serum free light chains: an alternative to the urine Bence Jones proteins screening test for monoclonal gammopathies. Hill PG; Forsyth JM; Rai B; Mayne S Clin Chem; 2006 Sep; 52(9):1743-8. PubMed ID: 16858075 [TBL] [Abstract][Full Text] [Related]
68. Long-term biological variation of serum protein electrophoresis M-spike, urine M-spike, and monoclonal serum free light chain quantification: implications for monitoring monoclonal gammopathies. Katzmann JA; Snyder MR; Rajkumar SV; Kyle RA; Therneau TM; Benson JT; Dispenzieri A Clin Chem; 2011 Dec; 57(12):1687-92. PubMed ID: 21980167 [TBL] [Abstract][Full Text] [Related]
69. The association of serum-free light-chain levels with markers of renal function. Erdem BK; Davran F; Yilmaz VT; Çetinkaya R; Akbas H Ren Fail; 2015 Jul; 37(6):1057-60. PubMed ID: 26056734 [TBL] [Abstract][Full Text] [Related]
70. Verification study of free light chains assays on reagent-optimized analysers. Šegulja D; Matišić D; Barišić K; Rogić D Biochem Med (Zagreb); 2019 Oct; 29(3):030709. PubMed ID: 31624462 [TBL] [Abstract][Full Text] [Related]
71. Analytical Criticalities Associated to Different Immunological Methods for Serum Free Light Chain Detection in Plasma Cell Dyscrasias: A Description of Particular Clinical Cases. Sabatino R; Perrone A; Cuomo M; Liotti S; Barchiesi V; Cantile M; Cavalcanti E Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417905 [TBL] [Abstract][Full Text] [Related]
72. [Analysis of the relationship of heavy/light chain pairs of immunoglobulin (Hevylite) to the results of gel electrophoresis and nefelometric examination of serum proteins at the time of multiple myeloma diagnosis]. Ščudla V; Lochman P; Pika T; Zapletalová J; Minařík J; Bačovský J Cas Lek Cesk; 2015; 154(6):292-302. PubMed ID: 26750626 [TBL] [Abstract][Full Text] [Related]
73. Comparison of 2 Serum-Free Light-Chain Assays in CKD Patients. Sprangers B; Claes K; Evenepoel P; Kuypers D; Poesen K; Delforge M; Bossuyt V X; Meijers B Kidney Int Rep; 2020 May; 5(5):627-631. PubMed ID: 32405584 [TBL] [Abstract][Full Text] [Related]
74. Reply to "Accuracy of determination of free light chains (Kappa and Lambda) in plasma and serum by Swedish laboratories as monitored by external quality assessment". de Kat Angelino CM; Jacobs JFM Clin Biochem; 2023 Feb; 112():73-74. PubMed ID: 36509148 [No Abstract] [Full Text] [Related]
75. Relationship between circulating syndecan-1 levels (CD138s) and serum free light chains in monoclonal gammopathies. Cigliana G; Torti E; Gulli F; De Santis E; Dell'Abate MT; Colacicco L; Pisani F; Conti L; Basile U J Exp Clin Cancer Res; 2015 Apr; 34(1):37. PubMed ID: 26025441 [TBL] [Abstract][Full Text] [Related]
76. Free light chains and heavy/light chains in monitoring POEMS patients. Altinier S; Proko K; Zaninotto M; Ciubotaru D; Seguso M; Varagnolo M; Lessi F; Briani C; Adami F; Plebani M Clin Chem Lab Med; 2016 Jun; 54(6):1065-71. PubMed ID: 27071150 [TBL] [Abstract][Full Text] [Related]
77. Prognostic value of involved/uninvolved free light chain ratio determined by Freelite and N Latex FLC assays for identification of high-risk smoldering myeloma patients. Henriot B; Rouger E; Rousseau C; Escoffre M; Sébillot M; Bendavid C; Minvielle S; Avet-Loiseau H; Decaux O; Moreau C Clin Chem Lab Med; 2019 Aug; 57(9):1397-1405. PubMed ID: 30973821 [TBL] [Abstract][Full Text] [Related]